Kwality Pharmaceuticals Ltd
BSE:539997
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| IN |
|
Kwality Pharmaceuticals Ltd
BSE:539997
|
12.1B INR |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
992.9B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
575.5B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
282.2B CHF |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
231.1B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.7B GBP |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
291.1B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
153.9B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.2B USD |
Loading...
|
Market Distribution
| Min | -305 007.7% |
| 30th Percentile | 2.1% |
| Median | 5.8% |
| 70th Percentile | 11.6% |
| Max | 1 221 633.3% |
Other Profitability Ratios
Kwality Pharmaceuticals Ltd
Glance View
Kwality Pharmaceuticals Pvt Ltd. engages in the manufacture of pharmaceutical formulations in dosage form. The company is headquartered in Amritsar, Punjab. The company went IPO on 2016-07-18. The firm operates through the segment of manufacturing a range of finished pharmaceutical formulations in a dosage form, such as tablets, liquid orals, powder for oral suspension, tablets, capsules, sterile powder for injections, small volume injectables, ointments, external preparations and oral rehydration solutions (ORS), among others. The company provides pharmaceutical formulations in various categories, such as beta-lactam and non-beta lactam, hormones and cytotoxic (oncology). The company manufactures beta-lactam and cephalosporin molecules in various dosage forms, such as tablets, capsules, dry powder for suspension and dry powder for injection. The company manufactures the anticancer products in various dosage forms, such as tablets, capsules and injectables. Its products are available in Europe, Africa and Asian countries, among others.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Kwality Pharmaceuticals Ltd is 11.6%, which is above its 3-year median of 8.1%.
Over the last 3 years, Kwality Pharmaceuticals Ltd’s Net Margin has decreased from 16.4% to 11.6%. During this period, it reached a low of 4.2% on Dec 31, 2023 and a high of 16.4% on Aug 30, 2022.
